Aetion Evidence

by Aetion, a Datavant Company  · Based in United States → — Transforming real-world data into decision-grade real-world evidence for healthcare's most critical decisions.
Cardiology Neurology Oncology
Website
Claim this tool
Is this the maker? Claim the company →

Enterprise
Regulatory Status Disclosed

Overview

Aetion is a healthcare analytics company that delivers real-world evidence (RWE) solutions. Its flagship offering, the Aetion Evidence Platform® (AEP), analyzes real-world data (RWD) from diverse sources such as electronic health records, insurance claims, and lab tests. The platform is designed to generate transparent, rapid, and scientifically validated insights on the safety, effectiveness, and value of medical treatments and technologies. Aetion supports biopharmaceutical companies, medical device manufacturers, payers, and regulatory agencies in making informed decisions for product development, commercialization, regulatory submissions, and payment innovation. Founded by Harvard Medical School faculty, Aetion leverages validated epidemiologic methods and causal inference to produce regulatory-grade evidence aligned with global standards like those from the FDA and EMA. In July 2025, Aetion was acquired by Datavant, integrating its RWE capabilities into Datavant’s broader health data ecosystem.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Real-World Evidence (RWE) Generation
  • Validated Causal Inference & Analytical Methods
  • Transparent Audit Trails & Reproducibility
  • No-Code Dynamic Workflows
  • AI-Driven Synthetic Data Generation (Aetionu00ae Generate)
  • Longitudinal Data Management
  • Regulatory-Grade Evidence (FDA, EMA aligned)
  • Exploratory Analysis (Aetionu00ae Discover)
  • High-Impact Study Implementation (Aetionu00ae Substantiate)
  • Secure Collaboration Workbench (Aetionu00ae Activate)

Use Cases

  • Regulatory Submissions and Affairs
  • Health Technology Assessment (HTA) & Market Access
  • Clinical Trial Optimization and Strategy
  • Post-market Safety and Effectiveness Assessments
  • Drug Development and Commercialization
  • Evidence generation for payers and health plans

What Physicians Need to Know

Real-World Evidence Analysis
Aetion Evidence Platform (AEP) is a modular, data-agnostic platform designed for rigorous, decision-grade real-world evidence (RWE) generation across clinical, regulatory, and commercial functions. It transforms real-world data (RWD) into insights using validated epidemiologic methods and causal inference. The platform accelerates time-to-insights, potentially reducing RWE initiative completion time by up to 50%. It supports regulatory-grade RWE generation, aligning with standards from bodies like the FDA and EMA.
Clinical Trial Matching & Optimization
Aetion helps optimize clinical trials by identifying target populations, creating external control arms, and contextualizing settings and populations underrepresented in controlled trials. The platform can replicate clinical trial results using RWE to understand drug effectiveness. Aetion's Generate: Enhance solution uses generative models and sequential synthesis to simulate missing patients and restore trial power in under-enrolled studies, particularly relevant for Phase 2 trials.
Safety Signal Detection
Aetion's platform supports safety evaluation and monitoring using RWD. Real-world data, including claims and electronic health records, are increasingly used for drug safety signal detection and post-marketing surveillance. Aetion's collaboration with the FDA included using the Evidence Platform to categorize patients, prescribed medications, and adverse effects to inform treatment decisions.
Genomic Data Integration
While not a primary focus, AI can integrate data from multiple sources, including genomic data, to develop personalized treatment regimens and identify biomarkers for drug efficacy and safety. Integrating genomic data with population-level observational data offers a comprehensive view of health outcomes, though it presents challenges in privacy and security.
Collaboration Features
The Aetion Evidence Platform includes 'Aetion Activate,' a secure, flexible collaboration workbench for data preparation, cleaning, querying, and hosting secure coding environments like RStudio. This facilitates collaboration across different user types and ensures data prepared maintains scientific rigor.
Publication Support
Aetion provides publication strategy support as part of its ecosystem for real-world evidence generation. The company's work, including studies applying generative models for data augmentation, has contributed to numerous peer-reviewed publications. Aetion also publishes whitepapers and articles on its 'Evidence Hub' related to RWD and RWE.
AI/ML-Driven Analytics & Synthetic Data Generation
Aetion leverages AI/ML services, including Amazon Bedrock, to enhance predictive modeling, patient stratification, and analysis automation. AetionAI, a set of generative AI capabilities, is embedded across the platform. The 'Aetion Generate' application uses generative AI for synthetic health data generation, safeguarding privacy while ensuring utility, and helps address data privacy regulations, cross-border restrictions, and RWD gaps. This includes features like 'Measures Assistant' to translate natural language scientific intent into analytical measures and 'Smart Subgroups Interpreter' for discovering patterns in patient populations.
Physician Tip

For physicians engaging with Aetion Evidence, focus on how the platform's real-world evidence (RWE) capabilities can inform clinical decision-making, particularly regarding treatment effectiveness and safety in diverse patient populations often underrepresented in traditional trials. The ability to analyze real-world data (RWD) can provide insights into how different patients react to medications and identify optimal treatment strategies. Leverage the platform's AI-driven analytics for patient stratification and understanding disease progression across subgroups. The collaboration features, like Aetion Activate, can facilitate discussions and analyses with research teams to address specific clinical questions. The synthetic data generation capabilities can also be valuable for exploring hypotheses in a privacy-preserving manner.

The Aetion Evidence Platform is built on a secure, scalable cloud infrastructure powered by Amazon Web Services (AWS), leveraging services like Amazon Bedrock for AI/ML capabilities. It integrates with Datavant for data linkage and Databricks for data processing and analytics. Aetion Activate supports integration with RStudio for secure coding environments. Aetion has also partnered with various organizations to enhance its data sources and capabilities, including HealthVerity for comprehensive, real-time data, Cegedim Health Data for European RWD, and Sanofi's DARWIN platform.

Details

Category Drug Discovery & Research, Population Health Analytics
Pricing Enterprise
  • Pricing is based on the duration and terms of a contract with the vendor, typical for an enterprise-level, high-value RWE platform
  • An example for a 12-month contract in AWS Marketplace is $600,000.00; contact Aetion for private offers
DeploymentCloud, SaaS
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Not applicable AI-estimated

The Aetion Evidence Platform is designed to generate regulatory-grade real-world evidence aligned with FDA and EMA standards. Aetion has research collaborations with the FDA to advance regulatory science and understanding of medical countermeasures.
Integrations
EHR Not specified
Specialties Cardiology, Neurology, Oncology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Aetion Evidence

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

BioSpace
Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data
Datavant announced its agreement to acquire Aetion, aiming to create an end-to-end real-world evidence (RWE) platform for healthcare and life sciences companies to efficiently answer research questions about therapies. The acquisition will combine Datavant's data connectivity with Aetion's RWE platform and scientific expertise.
2025-05
PR Newswire
Aetion Launches Aetionu00ae Evidence Platform Availability in AWS Marketplace, Accelerating Real-World Evidence Benefits for its Customers
Aetion announced the availability of its Aetionu00ae Evidence Platform (AEP) in Amazon Web Services (AWS) Marketplace, simplifying procurement and enabling life sciences organizations, payers, and regulators to leverage scalable, cloud-based evidence generation. This move aims to accelerate real-world evidence benefits for customers by removing implementation barriers.
2025-03
Artificial Intelligence (AWS Blog)
How Aetion is using generative AI and Amazon Bedrock to translate scientific intent to results
Aetion is leveraging generative AI and Amazon Bedrock to enhance its Aetion Evidence Platform (AEP), enabling scientists to more flexibly capture complex patient variables and accelerate the process of turning real-world data into real-world evidence. This technology aims to unlock hidden insights about patient populations and improve the user experience.
2025-02
Pharmacy Times
Aetion Collaborates With FDA to Explore Oncology RWD for Regulatory Science Research
Aetion announced a five-year research collaboration with the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) to advance research using novel oncology real-world data (RWD) sources through its Aetion Evidence Platform. The collaboration aims to address key research questions relevant to cancer prevention, clinical care, diagnostics, and treatment.
2023-01
PubMed (Clinical Pharmacology & Therapeutics)
The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology
This article describes the Aetion Coalition for the Advancement of RWE through Randomized Controlled Trial Emulation (CARE) Initiative, focusing on oncology. The initiative aims to understand when real-world data can provide reliable conclusions on drug effectiveness by emulating randomized controlled trials.
2023-06
Friends of Cancer Research
Aetion Leads Cross Industry Initiative to Understand Strengths and Limitations of Regulatory Use of Real-World Evidence - Friends of Cancer Research
Aetion launched the Coalition for the Advancement of RWE through Randomized Controlled Trial Emulation (CARE) Initiative, with an initial focus on oncology. This cross-industry effort aims to understand the types of regulatory questions that can be answered using RWE and randomized controlled trials.
2022-11
PR Newswire
FDA Selects Aetion Evidence Platformu00ae to Advance Regulatory Science and Innovation
Aetion expanded its relationship with the U.S. Food and Drug Administration (FDA) to use its Aetion Evidence Platformu00ae for studying COVID-19 interventions and advancing regulatory science. This project aims to demonstrate how a platform-based approach can further regulatory learnings on RWE use for decision-making.
2021-10
Sanofi US News
Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence
Sanofi announced an enterprise-wide collaboration with Aetion to integrate Sanofi's real-world data platform, DARWIN, with the Aetion Evidence Platform. The objective is to advance the efficient use of real-world evidence, facilitate regulatory-grade studies, and unlock access to new real-world data.
2019-11

Videos

Product demos, reviews, and walkthroughs for Aetion Evidence.

View all on YouTube

Frequently Asked Questions

Aetion Evidence is a real-world evidence (RWE) platform that uses advanced analytics and AI/machine learning to analyze real-world data (RWD) from various sources like electronic health records and claims. It helps generate regulatory-grade evidence on the effectiveness, safety, and value of medical products, aiding in clinical development, market access, and post-market surveillance.
Aetion Evidence prioritizes data privacy and security, adhering to regulations like HIPAA and GDPR. The platform typically works with de-identified or anonymized patient data, meaning individual patient identities are protected.
Yes, there are other platforms and approaches for generating real-world evidence. Alternatives include other RWE technology providers, academic research institutions, and in-house analytics teams at pharmaceutical companies. Differentiators often lie in the specific methodologies, data sources, therapeutic area expertise, and the level of regulatory acceptance of their evidence generation.
While specific pricing details are not publicly disclosed, RWE platforms like Aetion Evidence typically operate on a subscription or project-based model. The cost can vary significantly depending on the scope of work, the duration of the project, the volume of data analyzed, and the specific modules or services utilized.
While powerful, Aetion Evidence's analysis of real-world data can be subject to limitations inherent in RWD, such as data completeness, accuracy, and potential biases from observational study designs. Physicians should be aware of potential confounding factors, selection bias, and information bias that can influence the interpretation of results.
Aetion Evidence typically works with various sources of real-world data, which can include de-identified data extracted from EHR systems. The specific integration capabilities would depend on the existing EHR system and the data governance agreements in place.
Aetion Evidence employs robust methodologies, including validated analytic techniques and transparent reporting, to ensure the accuracy and reliability of the real-world evidence it generates. They often collaborate with regulatory bodies and academic experts to refine their approaches and ensure the scientific rigor of their findings.

Related Tools

MyTrials.ai
MyTrials.ai
Drug Discovery & Research
MyTrials.ai is an AI-powered platform for clinical trial recruitment, combining a verified patient network, intelligent matching, and human navigators to accelerate enrollment.
HypeCheck
2 Minute Medicine
Clinical Decision Support & Reference
HypeCheck™ instantly evaluates health articles, wellness advice, and viral trends by cross-referencing them directly against peer-reviewed literature on PubMed, active clinical trials, and official health agency guidance.
$4.99/month or $49.90/year
Scite
Scite
Drug Discovery & Research
Scite is an AI research tool that shows how papers have been cited, providing context on whether findings are supported or contradicted by subsequent research, which is valuable for medical writers and researchers.
Tiered pricing model with free, basic, premium, premium+, group, and enterprise plans.
Google Bard
Google
Clinical Decision Support & Reference
Google Bard, now known as Gemini, is a generative AI model that can assist healthcare professionals with tasks such as summarizing medical records and research papers, generating hypotheses, and providing information on medical conditions.
Freemium
AIDDISON Explorer
Sigma-Aldrich (Merck KGaA)
Drug Discovery & Research
AIDDISSON Explorer is an AI-powered drug discovery platform combining generative AI with computer-aided drug design for molecular generation, virtual screening, ADMET prediction, and retrosynthesis planning.
Noodle Biomedical Literature Discovery
Helena Bioinformatics
Drug Discovery & Research
Noodle is a biomedical literature discovery platform that allows researchers to search publications by meaning, inspect paper details, and explore related evidence through citation connections and semantic neighborhoods. It offers a public read-only Model Context Protocol (MCP) interface for AI agents.
Free

See all Drug Discovery & Research tools →

Suggest an Edit → | Last Verified: 2026-06-11 | First Added: 2026-06-11
AI Tool Finder
AI-powered search. Results may not be comprehensive.